Bank of New York Mellon
ISEE

Bank of New York Mellon’s IVERIC bio, Inc. Common Stock ISEE Stock Holding History

Bank of New York Mellon’s Portfolio ISEE Stock Details ISEE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-561,251
Closed -$22.1M – 4475
2023
Q2 		$22.1M Buy
561,251
+12,316
+2% +$435K ﹤0.01% 1495
2023
Q1 		$13.4M Sell
548,935
-30,741
-5% -$673K ﹤0.01% 1771
2022
Q4 		$12.4M Buy
579,676
+134,519
+30% +$2.87M ﹤0.01% 1825
2022
Q3 		$7.99M Buy
445,157
+60,200
+16% +$790K ﹤0.01% 2031
2022
Q2 		$3.7M Sell
384,957
-102,044
-21% -$1.28M ﹤0.01% 2483
2022
Q1 		$8.2M Buy
487,001
+36,387
+8% +$538K ﹤0.01% 2181
2021
Q4 		$7.53M Buy
450,614
+24,423
+6% +$400K ﹤0.01% 2254
2021
Q3 		$6.92M Buy
426,191
+125,884
+42% +$1.37M ﹤0.01% 2329
2021
Q2 		$1.9M Sell
300,307
-42,581
-12% -$275K ﹤0.01% 3014
2021
Q1 		$2.12M Buy
342,888
+465
+0.1% +$2.82K ﹤0.01% 2896
2020
Q4 		$2.37M Buy
342,423
+89,743
+36% +$574K ﹤0.01% 2747
2020
Q3 		$1.43M Buy
252,680
+107,694
+74% +$514K ﹤0.01% 2892
2020
Q2 		$739K Buy
144,986
+123,342
+570% +$514K ﹤0.01% 3272
2020
Q1 		$74K Hold
21,644
– – ﹤0.01% 3908
2019
Q4 		$186K Sell
21,644
-680
-3% -$2.43K ﹤0.01% 3932
2019
Q3 		$25K Hold
22,324
– – ﹤0.01% 4169
2019
Q2 		$29K Hold
22,324
– – ﹤0.01% 4167
2019
Q1 		$31K Sell
22,324
-672
-3% -$940 ﹤0.01% 4130
2018
Q4 		$28K Sell
22,996
-25,370
-52% -$49.2K ﹤0.01% 4120
2018
Q3 		$114K Sell
48,366
-1,459
-3% -$3.64K ﹤0.01% 4019
2018
Q2 		$136K Sell
49,825
-4,443
-8% -$12.3K ﹤0.01% 3964
2018
Q1 		$149K Sell
54,268
-4,264
-7% -$12.4K ﹤0.01% 3988
2017
Q4 		$183K Buy
58,532
+4,014
+7% +$11.3K ﹤0.01% 3969
2017
Q3 		$154K Buy
54,518
+1,591
+3% +$4.3K ﹤0.01% 3926
2017
Q2 		$136K Sell
52,927
-76,175
-59% -$208K ﹤0.01% 3970
2017
Q1 		$472K Sell
129,102
-325
-0.3% -$1.37K ﹤0.01% 3581
2016
Q4 		$625K Sell
129,427
-35,611
-22% -$1.06M ﹤0.01% 3489
2016
Q3 		$7.61M Sell
165,038
-4,225
-2% -$238K ﹤0.01% 2003
2016
Q2 		$8.64M Buy
169,263
+26,652
+19% +$1.32M ﹤0.01% 1932
2016
Q1 		$6.03M Buy
142,611
+7,775
+6% +$396K ﹤0.01% 2083
2015
Q4 		$10.6M Buy
134,836
+24,313
+22% +$1.41M ﹤0.01% 1807
2015
Q3 		$4.48M Buy
110,523
+7,145
+7% +$379K ﹤0.01% 2301
2015
Q2 		$5.38M Buy
103,378
+9,071
+10% +$451K ﹤0.01% 2309
2015
Q1 		$4.39M Sell
94,307
-4,860
-5% -$252K ﹤0.01% 2380
2014
Q4 		$4.45M Buy
99,167
+8,193
+9% +$344K ﹤0.01% 2367
2014
Q3 		$3.54M Buy
90,974
+8,748
+11% +$343K ﹤0.01% 2513
2014
Q2 		$3.48M Buy
82,226
+38,003
+86% +$1.39M ﹤0.01% 2548
2014
Q1 		$1.58M Buy
44,223
+13,083
+42% +$441K ﹤0.01% 3035
2013
Q4 		$1.01M Buy
+31,140
New +$924K ﹤0.01% 3308

Bank of New York Mellon's ISEE Position: Q3 2023 in Review

Bank of New York Mellon sold out of IVERIC bio, Inc. Common Stock (ISEE) in Q3 2023, closing a stake of 561,251 shares — an estimated $22.1M sold.

Bank of New York Mellon first reported a position in ISEE in Q4 2013 and held it in 39 quarters. The position peaked at $22.1M in Q2 2023. 0 funds tracked by Wall St. Rank hold ISEE as of Q3 2023.

  • Bank of New York Mellon reported no remaining IVERIC bio, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
  • Bank of New York Mellon sold 561,251 IVERIC bio, Inc. Common Stock shares in Q3 2023, an estimated $22.1M.
  • Bank of New York Mellon first reported a position in IVERIC bio, Inc. Common Stock in Q4 2013 and held it in 39 quarters.
  • Bank of New York Mellon's IVERIC bio, Inc. Common Stock position peaked at $22.1M in Q2 2023.
  • 0 funds tracked by Wall St. Rank held IVERIC bio, Inc. Common Stock as of Q3 2023.

Based on Bank of New York Mellon's 13F filing for Q3 2023, filed 24 Oct 2023.